Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

2010-10-01

Additional Metadata
Persistent URL	doi.org/10.1016/j.eururo.2010.07.016, hdl.handle.net/1765/27943
Journal	European Urology : Official Journal of the European Association of Urology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schenk-Braat, E. (2010). Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. European Urology : Official Journal of the European Association of Urology (Vol. 58, pp. 632–633). doi:10.1016/j.eururo.2010.07.016

Publication